Induction of inflammation in mice using IL-1β, LPS, and/or TNF correlates with increased expression levels of FGF-23 in osteocytes, both in humans and in mice [164], but also in CKD and inflammation in other organs [165]. Here, FGF23 is linked to chronic kidney disease.